In vitro targeting of synthesized antibody-conjugated dendrimer nanoparticles

Biomacromolecules. 2004 Nov-Dec;5(6):2269-74. doi: 10.1021/bm049704h.

Abstract

This study reports the synthesis and in vitro biological properties of dendrimer-antibody conjugates. The polyamidoamine dendrimer platform was conjugated to fluorescein isothiocyanate as a means to analyze cell binding and internalization. Two different antibodies, 60bca and J591, which bind to CD14 and prostate-specific membrane antigen (PSMA), respectively, were used as model targeting molecules. The binding of the antibody-conjugated dendrimers to antigen-expressing cells was evaluated by flow cytometry, confocal microscopy, and a new two-photon-based optical fiber fluorescence detection system. The conjugates specifically bound to the antigen-expressing cells in a time- and dose-dependent fashion, with affinity similar to that of the free antibody. Confocal microscopic analysis suggested at least some cellular internalization of the dendrimer conjugate. Dendrimer-antibody conjugates are a suitable platform for targeted molecule delivery into antigen-expressing cells.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Antigens / chemistry
  • Antigens, Surface / chemistry
  • Binding, Competitive
  • Cell Line, Tumor
  • Dose-Response Relationship, Drug
  • Flow Cytometry
  • Glutamate Carboxypeptidase II / chemistry
  • HL-60 Cells
  • Humans
  • Hybridomas / metabolism
  • Jurkat Cells
  • Lipopolysaccharide Receptors / biosynthesis
  • Lipopolysaccharide Receptors / chemistry
  • Macromolecular Substances / chemistry*
  • Microscopy, Confocal
  • Microscopy, Fluorescence
  • Models, Chemical
  • Nanotechnology / methods*
  • Photons
  • Protein Binding
  • Scattering, Radiation
  • Time Factors

Substances

  • Antigens
  • Antigens, Surface
  • Lipopolysaccharide Receptors
  • Macromolecular Substances
  • FOLH1 protein, human
  • Glutamate Carboxypeptidase II